U.S. FDA Approves Prezista (darunavir) for Use in Pregnant Women with HIV

TITUSVILLE, N.J., July 18, 2016 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion to the Prezista (darunavir) U.S. Prescribing...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news

Related Links:

Despite the medical advances that have occurred in recent times, the risks associated with pregnancy have not declined, and in fact, maternal mortality is on the increase. What needs to be done?American Journal of Public Health
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
Many women have a period tracker or fertility app on their smartphone to monitor their menstrual cycle or help them plan or prevent pregnancy but a new review finds that they could be misleading women.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
A majority of pregnant women who are diagnosed with coronavirus don't experience more severe illness than the general population, according to a new study.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
No abstract available
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Case reports Source Type: research
Women turning to technology to avoid getting pregnant should exercise 'caution' according to new research. Fertility apps to help prevent an unwanted pregnancy may not work, experts are warning.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conclusions: Results indicate that maternal thyroid conditions are associated with increased ASD risk in progeny, but suggestively not due to direct effects of thyroid hormones. Instead, factors that influence maternal thyroid function could have etiologic roles in ASD through pathways independent of maternal gestational thyroid hormones and thus be unaffected by medication treatment. Factors known to disrupt thyroid function should be examined for possible involvement in ASD etiology.
Source: Epidemiology - Category: Epidemiology Tags: Women’s Health Source Type: research
Conclusion: Blood transfusion was documented with reasonable sensitivity in this large population perinatal database. However, validity varied according to risk factor status. Our findings enable researchers to better account for outcome misclassification in studies of obstetrical transfusion risk factors.
Source: Epidemiology - Category: Epidemiology Tags: Women’s Health Source Type: research
The fetal hypothalamus-pituitary gonadal (HPG) axis begins to function during mid-gestation but its activity decreases during late pregnancy due to the suppressive effects of placental estrogens. Placental hormones drop immediately after birth, FSH and LH surge at around 1 week and peak between 1 and 3 months of life. The HPG axis is activated in both sexes, but a sexual dimorphism is evident with higher LH values in boys, while FSH prevails in girls. Both gonadotrophins decline in boys by around 6 months of age. In girls, LH declines at the same time as in boys, while FSH persists elevated up to 3 or 4 years of age. As a ...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Conclusion: Based on new research, we recommend the 2017 ATA Guidelines be updated to recommend against treating thyroid antibody-negative women diagnosed with subclinical hypothyroidism in the second trimester or later; to reflect new, moderate-quality evidence supporting the treatment of thyroid peroxidase antibody-negative women with elevated thyroid stimulating hormone levels in the first trimester or earlier; and to recommend against treatment of euthyroid, thyroid peroxidase antibody-positive women undergoing assisted reproductive technology. Transitioning to a Dynamic ATA Guidelines would allow for these and future ...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Also: FDA clears Nuvo Group's fetal and maternal heart monitor for pregnant women; Innovaccer, Sanitas USA launch virtual COVID-19 care app.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Pregnancy | Prezista | Women